Healthy men test drug interaction: vimseltinib and metformin
NCT ID NCT07158411
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 34 times
Summary
This completed Phase 1 study looked at how vimseltinib affects the way the body processes metformin, a common diabetes drug. Twenty-two healthy men took vimseltinib and metformin to measure drug levels and check for side effects. The goal was to understand drug interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
vimseltinib
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.